Axios Today reports: Democrats are going ahead with a mostly virtual convention, starting tonight. But how TV networks will cover the event, and how the millions of American voters watching it will react is still up in the air.
Guests: Axios’ Margaret Talev, Jonathan Swan, and Facebook COO Sheryl Sandberg.
WASHINGTON POST (AUG 16, 2020): Researchers in the United States set an audacious goal in January to develop a coronavirus vaccine within 12 to 18 months. This would be a world record. The mumps vaccine is considered to be the fastest to move, in four years, from scientific concept to approval in 1967. The quest for an HIV vaccine continues, 36 years and counting.
The Economist Magazine presents a selection of three essential articles read aloud from the latest issue of The Economist. This week, Xi Jinping is reinventing state capitalism (10:20), Belarus’s sham election (14:25), and the decline of the office romance.
DW Radio News 24/7 reports: Recently arrested Hong Kong media CEO Jimmy Lai vow that pro-democracy protests against China will continue, Belarus protests, and WHO reports 300,000 new Covid-19 cases in last 24 hours.
NPR News Now reports: The political issues surrounding operational changes at the Post Office, Iowa power outages after this week’s storms and California blackouts.
Syndicated columnist Mark Shields and New York Times columnist David Brooks join Judy Woodruff to discuss the week in politics, including former Vice President Joe Biden’s choice of Sen. Kamala Harris as his running mate, the legislative stalemate over federal coronavirus relief and President Trump’s ongoing campaign against mail-in voting and the U.S. Postal Service.
NPR News Now reports: Congress and the White House battle over a new stimulus bill, UAE in talks to normalize relations with Israel, Afghanistan and Taliban prisoners, and other world news.
NEJM (Aug 13, 2020) – Population-level mortality from NSCLC in the United States fell sharply from 2013 to 2016, and survival after diagnosis improved substantially. Our analysis suggests that a reduction in incidence along with treatment advances — particularly approvals for and use of targeted therapies — is likely to explain the reduction in mortality observed during this period.
“The survival benefit for patients with non-small cell lung cancer treated with targeted therapies has been demonstrated in clinical trials, but this study highlights the impact of these treatments at the population level,” said Nadia Howlader, Ph.D., of NCI’s Division of Cancer Control and Population Sciences, who led the study. “We can now see the impact of advances in lung cancer treatment on survival.”
Staff Writer Robert Service talks with host Sarah Crespi about a different approach to COVID-19 testing that might be useful in response to the high numbers of cases in the United States. To break chains of transmission and community spread, the new strategy would replace highly accurate but slow polymerase chain reaction (PCR) tests with cheaper, faster tests that are less accurate but can be administered frequently.
Such tests cost between $1 and $3 compared with more than $100 for diagnostic PCR tests and give results in less than 30 minutes instead of days. Read all of our coronavirus coverage here. Also this week, Salma Mousa, a postdoctoral fellow at Stanford University, joins Sarah to talk about an experiment that added Muslim players to teams in a Christian soccer league in northern Iraq. The goal of the study was to see whether this type of social contact would change how the Christians—a threatened minority in the region—behaved toward Muslims, on and off the field.
Intellicurious 